The federal government just launched a CMS program giving America's seniors access to hemp, marijuana products through Medicare. There's one problem: Europe's top scientists just said they can't ...

Asset Value Investors Limited (“AVI”) today announced an update to its public campaign regarding Rohto Pharmaceutical Co., Ltd. (TSE: 4527, “Rohto”), as a follow-up to its ongoing campaign, “Awakening ...

Actio launches dedicated patient resource to support families seeking information about the KYRON clinical trial at ...

"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, ...

VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc.

April was characterized by a high level of activity across several areas. We continue to see strong interest in Dosell, both ...

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...

Zacks increases 2026 revenue estimate to $103.2 million, up from $98.6 million in its prior January 2026 reportEPS outlook upgraded: Zacks now expects Cosmos Health to cross into positive EPS ...

WASHINGTON, D.C. / ACCESS Newswire / May 8, 2026 / The Hospital Accountability Project convened a roundtable of leading health policy experts this week to examine abuse in the federal 340B Drug ...

Veteran trial lawyer honored on 2026 list for excellence in mass tortsDALLAS--(BUSINESS WIRE)--Ben C. Martin, founding partner of the elite personal injury law firm Ben Martin Law Group, has been ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...